| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |